Taxwise or Otherwise

"Taxwise or Otherwise" discusses the latest developments in tax and business law in the Philippines. It also dissects current issues affecting the business community, including policy development. 

Writers are taken from a pool of business and tax consultants of Isla Lipana & Co., the Philippine member firm of PricewaterhouseCoopers global network. Columns regularly appear in the BusinessWorld newspaper.

Latest column

Drug companies made to take a bitter pill
By Jo Katrina V. Brotonel, 29 October 2009

On June 6, 2008, President Gloria Macapagal-Arroyo signed into law Republic Act 9502, also known as the "Universally Accessible Cheaper and Quality Medicines Act of 2008," which aims to promote and ensure equal access to affordable quality drugs and medicines.

One year down the road, this piece of legislation has become more relevant as calamity-stricken Juan dela Cruz, barely recovering from the wrath of Ondoy and Pepeng, now faces the outbreak of flood-related diseases.With the soaring prices of medicines to combat these diseases, RA 9502 may be a timely state-intervention through meaningful legislation.It would have made a very sweet ending, but because it failed to address other implications such as relevant tax consequences to those affected, it has somehow turned into a bitter pill to be swallowed, eyes closed, by the pharmaceutical industry.

Read column: Drug companies made to take a bitter pill

Past columns

To access previous Taxwise or Otherwise columns, please contact:
Lyn Golez, Tax services